international consortium for health outcomes measurement
TRANSCRIPT
International Consortium for Health Outcomes Measurement
Dr James Kent, BCGDr Tom Kelley, ICHOM
Kings Fund 18th November 2014
141118-ICHOM-Kings Fund-Final.pptx 1Copyright © 2013 by the International Consortium for Health Outcomes Measurement. All rights reserved.
Evolving healthcare systems
Outcomes
focused
Accountable care
...ensuring payments are
linked to outcomes
Integrated care
...ensuring many providers
can coordinate to deliver
outcomes
Value-based health
care
...ensuring decisions are
framed as outcomes over
input costs
Bundled care
..ensuring payment covers
all aspects of care around
a procedure
141118-ICHOM-Kings Fund-Final.pptx 2Copyright © 2013 by the International Consortium for Health Outcomes Measurement. All rights reserved.
Paucity of outcomes data
Where available, hard to compare
Too much time spend in 'definitions' meetings
Lack of standardisation
• Barrier to transparency
• Inability to compare and learn
• Slow pace of change
Problem
141118-ICHOM-Kings Fund-Final.pptx 3Copyright © 2013 by the International Consortium for Health Outcomes Measurement. All rights reserved.
Independent, not-for-profit
Focus on standards, not collecting data
Build on the best, selecting not redefining
Focus on outcomes that matter to patients▪ 'Minimum set'
Open source
Solution
141118-ICHOM-Kings Fund-Final.pptx 4Copyright © 2013 by the International Consortium for Health Outcomes Measurement. All rights reserved.
Define internationally recognized Standard Sets of outcomes
▪ Together with risk adjustment factors
Drive the adoption of Standard Sets globally
▪ Wide dissemination among clinicians and patient groups
Create global communities focused on outcome comparison
• Support learning, and practice improvement
Three objectives
1
2
3
141118-ICHOM-Kings Fund-Final.pptx 5Copyright © 2013 by the International Consortium for Health Outcomes Measurement. All rights reserved.
Localized Prostate Cancer Set
Treatment approaches covered
▪ Watchful waiting▪ Active surveillance▪ Prostatectomy▪ External beam radiation therapy ▪ Brachytherapy▪ Androgen Deprivation Treatment▪ Other
Details1 Recorded via the Clavien-Dindo-Classification2 Recorded via the Common Terminology Criteria for
Adverse Events (CTCAE), version 4.0 3 Recommended to track via the Expanded Prostate
Cancer Index Composite (EPIC)-26
141118-ICHOM-Kings Fund-Final.pptx 6Copyright © 2013 by the International Consortium for Health Outcomes Measurement. All rights reserved.
Prostate Cancer Working Group
Adam Glaser, St James’ Institute of Oncology; NHSJim Catto, University of Sheffield, European Urology
Kim Moretti, South Australian Prostate Cancer Clinical Outcome CollaborativeMark Frydenberg, Prostate Cancer Registry of VictoriaIan Roos*, Cancer Voices Victoria
Frank SullivanProstate Cancer InstituteJohn Fitzpatrick, Irish Cancer Society
Hartwig Huland and Markus Graefen, Martini KlinikMichael Froehner, Günter Feick*, Bundesverband Prostatakrebs Selbsthilfe (BPS); Europa UOMOThomas Wiegel, University Hospital Ulm
C.H. Bangma, Erasmus Medical Center
Anna Bill-Axelson, Swedish Prostate Cancer Registry
Francesco Montorsi, European Urology Editor in ChiefAlberto Briganti, Vita-Salute San Raffaele University Hospital, Milan
Jabob Ramon, Sheba Medical Center
Steven Jay Frank, MD AndersonDavid Swanson, MD AndersonAndrew Vickers, MSKCCAdam Kibel, Dana Farber/BWHMichael O’Leary, Dana Farber/BWHAnthony D’Amico, Dana Farber/BWHNeil Martin, Dana Farber/BWHMichael Blute, MGHHoward Sandler, Cedars-SinaiRonald Chen, University of North CarolinaDan Hamstra, University of MichiganAsh Tewari, Weill Cornell Medical College
*Patient representative
141118-ICHOM-Kings Fund-Final.pptx 7Copyright © 2013 by the International Consortium for Health Outcomes Measurement. All rights reserved.
Working Group process
After outcomes and measures are defined, a similar process follows to identify and define an
accompanying set of risk factors and initial conditions
141118-ICHOM-Kings Fund-Final.pptx 8Copyright © 2013 by the International Consortium for Health Outcomes Measurement. All rights reserved.
Up
for
Deb
ate
Criteria to prioritise outcomes
OutcomeFrequency
(5=high)Severity(5=high)
Avoidability(5=high)
Feasibility to capture
(5= easy)
Nerve root injury incl. cauda equina ++ ++++ +++ ++++
Deep wound infection (e.g., meningitis, discitis, osteitis) ++ +++++ +++ ++++
Pulmonary embolus + +++++ ++++ ++++
Wrong site procedure + ++++ +++++ +++++
Vascular injury + +++ +++ ++++
Dural tear/ CSF leak ++ ++ +++ +++
Wound dehiscence ++ ++ +++ ++++
Hematoma +++ ++ +++ +++
Superficial infection (cellulitis) +++ + +++ +++
Malpositioned implant ++ + +++ +++
Long OR/anesthesia time ++ + ++ ++++
Hemorrhage/blood transfusion required + + +++ ++++
Su
gg
est
Incl
ud
ing
Su
gg
est
no
t In
clu
din
g
Example: Complications after spine surgery, part of Low Back Pain Standard Set
141118-ICHOM-Kings Fund-Final.pptx 9Copyright © 2013 by the International Consortium for Health Outcomes Measurement. All rights reserved.
Criteria to select PROMs
* Pubmed search on "COMI, Back Pain, 2001-2011"Note: RoM, Range of Motion; FCE, Functional Capacity Evaluation; LBPRS, LBP rating scale; PSFS, Patient-specific functional scaleSource: Chapman et al, Measuring Treatment Success for Chronic Low Back Pain, Spine 2011; Mannion et al, Outcome assessment in low back pain: how low can you go?, Eur Spine J.,2005
ODI Roland Morris
COMI
# of languages (val.transl)
14 9 9
# of items 10 24 7
Valid Yes Yes Yes
Reliable Yes Yes Yes
Responsive Yes Yes Yes
Needs license Yes (no cost)
No No
Clinicalinterpret-ability
+++ + +
200
150
100
50
0
Trunk flex
PSFSSchoberLBP-RS
FCEQuebecRoMRoland Morris
ODI COMI*
# of citations
Top 10 frequently cited measures of
function in LBP (2001-2011)
ODI short and well translated, license
grants access to high-quality
translations
Example: Selecting the best measure of disability in Low Back Pain
141118-ICHOM-Kings Fund-Final.pptx 10Copyright © 2013 by the International Consortium for Health Outcomes Measurement. All rights reserved.
All Sets contain Patient Reported OutcomesS
tan
da
rd S
ets
PR
O t
oo
ls
MDS-UPDRS
NMSQuest
PDQ-8
Catquest 9SF ODI
NPS
EQ-5D
SAQ-7
PHQ-2
Rose
Cleft-Q
NOSE scale
141118-ICHOM-Kings Fund-Final.pptx 11Copyright © 2013 by the International Consortium for Health Outcomes Measurement. All rights reserved.
ICHOM Sets that we are developing
141118-ICHOM-Kings Fund-Final.pptx 12Copyright © 2013 by the International Consortium for Health Outcomes Measurement. All rights reserved.
Our Sets are used by 45+ institutions
Examples
▪ MD Anderson (US) – Localized Prostate Cancer
▪ Stanford University (US) – Low Back Pain
▪ The Ohio State University (US) – Low Back Pain
▪ Mayo Clinic (US) – Parkison's Disease
▪ Fortis Health Care (IN) – Coronary Artery Disease
▪ Aravind (IN) - Cataracts
▪ Martini Klinik (DE) – Localized Prostate Cancer
▪ Hamburg Brachytherapy (DE) –Localized Prostate Cancer
▪ Australian Prostate Cancer Clinical Registry (AU) – Localized Prostate Cancer
141118-ICHOM-Kings Fund-Final.pptx 13Copyright © 2013 by the International Consortium for Health Outcomes Measurement. All rights reserved.
Driving adoption in the UK
Existing collaborationSupporting the development
of our Sets
National adoptionSets used by nationalmeasurement efforts
Potential Pilot SitesLeading centres working to
use our Sets
141118-ICHOM-Kings Fund-Final.pptx 14Copyright © 2013 by the International Consortium for Health Outcomes Measurement. All rights reserved.
Creating communities: global network for CLP
Group of 12 hospitals formed – aim to begin collection mid 2015
141118-ICHOM-Kings Fund-Final.pptx 15Copyright © 2013 by the International Consortium for Health Outcomes Measurement. All rights reserved.
Define internationally recognized Standard Sets of outcomes
▪ Building on the best
Drive the adoption of Standard Sets globally
▪ Open Source to encourage roll-out
Create global communities
▪ Driving comparison, learning, and practice improvement
Recap: three objectives
1
2
3